Qube Research & Technologies LTD Royalty Pharma PLC Transaction History

Qube Research & Technologies LTD

$82.3 Billion
Q1 2025

A detailed history of Qube Research & Technologies LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,960,718 shares of RPRX stock, worth $66.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,960,718

Previous 1,589,497 23.35%

Holding current value

$66.2 Million

Previous $40.5 Million 50.53%

% of portfolio

0.07%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$25.75 - $33.86 $9.56 Million - $12.6 Million	371,221 Added 23.35%	1,960,718 $61 Million
Q4 2024 Feb 14, 2025	SELL	$24.28 - $28.39 $8.39 Million - $9.81 Million	-345,476 Reduced 17.85%	1,589,497 $40.5 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $6.56 Million - $7.49 Million	255,838 Added 15.24%	1,934,973 $54.7 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $23.9 Million - $27.2 Million	908,455 Added 117.88%	1,679,135 $44.3 Million
Q1 2024 May 14, 2024	SELL	$27.46 - $31.33 $35.6 Million - $40.6 Million	-1,294,847 Reduced 62.69%	770,680 $23.4 Million
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $9.3 Million - $10.4 Million	354,655 Added 20.73%	2,065,527 $58 Million
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $14 Million - $16.7 Million	531,529 Added 45.07%	1,710,872 $46.4 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $22.2 Million - $27.4 Million	750,586 Added 175.06%	1,179,343 $36.3 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $11.9 Million - $14.3 Million	-363,288 Reduced 45.87%	428,757 $15.4 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $18.4 Million - $20.6 Million	468,762 Added 145.0%	792,045 $31.3 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $10.6 Million - $11.9 Million	266,953 Added 473.91%	323,283 $13 Million
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $8.01 Million - $9.44 Million	-213,523 Reduced 79.13%	56,330 $2.37 Million
Q1 2022 May 09, 2022	BUY	$37.46 - $42.44 $7.91 Million - $8.97 Million	211,285 Added 360.75%	269,853 $10.5 Million
Q4 2021 Feb 01, 2022	SELL	$35.17 - $42.48 $866,448 - $1.05 Million	-24,636 Reduced 29.61%	58,568 $2.33 Million
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $135,235 - $158,062	-3,742 Reduced 4.3%	83,204 $3.01 Million
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $3.46 Million - $4.05 Million	86,946 New	86,946 $3.56 Million
Q4 2020 Feb 16, 2021	SELL	$36.12 - $50.05 $2.59 Million - $3.59 Million	-71,728 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$38.56 - $48.36 $2.77 Million - $3.47 Million	71,728 New	71,728 $3.02 Million

Others Institutions Holding RPRX

# of Institutions

484

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.8B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Royalty Pharma PLC Transaction History